Impact on immunogenicity of monovalent type 2 oral poliovirus vaccine

Findings from open-label phase IV, randomized controlled trial of mOPV2 alone and mOPV2 along with IPV
Findings from open-label phase IV, randomized controlled trial of mOPV2 alone and mOPV2 along with IPV